San Francisco, CA, United States of America

Roy K Hom

This inventor holds 24 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Alzheimer's Disease Treatment. Top assignees: Elan Pharmaceuticals, Inc., Imago Pharmaceuticals, Inc., Pharmacia & Upjohn Company. Active years: 2004-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roy K Hom. Retrieved from https://idiyas.com/inventor/roy-k-hom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 15)

% Patents Active = 12.5

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 147(Granted Patents)

Company Filing History:

21 out of 202

Elan Pharmaceuticals, Inc.

patents

3 out of 5

Imago Pharmaceuticals, Inc.

patents

2 out of 523

Pharmacia & Upjohn Company

where one patent can have more than one assignee

Years Active: 2004-2017

Loading Chart...

Areas of Expertise:

Alzheimer's Disease

Gamma Secretase

Polo-Like Kinase

Jun N-Terminal Kinase

Dipeptide Inhibitors

Spirocyclic Compounds

Thiazine Inhibitors

Hydroxypropane Derivatives

Sulfonamido Inhibitors

BACE Inhibitors

Pyrazolopyrrolidines

Dihydro-Oxazine

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9796706 - Inhibitors of Jun N-terminal kinase (2017-10-24),

2. 9493485 - Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof (2016-11-15),

3. 9073891 - Inhibitors of Jun N-terminal kinase (2015-07-07),

4. 8541418 - Inhibitors of polo-like kinase (2013-09-24),

5. 8450363 - Inhibitors of Jun N-terminal kinase (2013-05-28),

6. 8445503 - Inhibitors of polo-like kinase (2013-05-21),

7. 7977368 - Pyrazolopyrrolidines as inhibitors of gamma secretase (2011-07-12),

8. 7763646 - Compounds for the treatment of alzheimer's disease (2010-07-27),

9. 7754712 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase (2010-07-13),

10. 7727997 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives (2010-06-01),

11. 7553831 - Compounds to treat Alzheimer's disease (2009-06-30),

12. 7544717 - 2-amino- and 2-thio- substituted 1,3-diaminopropanes (2009-06-09),

13. 7345056 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase (2008-03-18),

14. 7276484 - Dipeptide inhibitors of β-secretase (2007-10-02),

15. 7223774 - Benzamide 2-hydroxy-3-diaminoalkanes (2007-05-29),

Title: The Innovative Journey of Roy K Hom

Introduction: Roy K Hom, a pioneering inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Roy K Hom's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Roy K Hom has established himself as a leading figure in the tech industry, having founded multiple successful startups and holding key positions in renowned tech companies. His innovative solutions have revolutionized various sectors, earning him recognition as a visionary inventor.

Collaborations: Throughout his career, Roy K Hom has collaborated with top researchers, engineers, and scientists to bring his inventions to life. His ability to foster strong partnerships and interdisciplinary collaborations has been instrumental in the success of his projects.

Conclusion: In conclusion, Roy K Hom's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a trailblazing inventor. His impact on the tech industry continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.